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Abstract In The Netherlands, relatively more patients
(20%) with amyotrophic lateral sclerosis (ALS) die due to
euthanasia or physician-assisted suicide (EAS) compared
with patients with cancer (5%) or heart failure (0.5%). We
wanted to gain insight into the reasons for ALS patients
requesting EAS and compare these with the reasons of
cancer and heart failure patients. Knowing disease-specific
reasons for requesting EAS may improve palliative care in
these vulnerable patients. The data used in the present
study were derived from the Support and Consultation in
Euthanasia in The Netherlands (SCEN) evaluation study.
This study provided consultation reports and questionnaires
filled out by the attending physicians from 3,337 consul-
tations conducted by SCEN physicians in situations where
a patient requested EAS. For this study we selected data on
all ALS patients (n = 51), all heart failure patients
(n = 61), and a random sample of 73 cancer patients. The
most frequently reported reasons for unbearable suffering
were: fear of suffocation (45%) and dependency (29%) in
ALS patients, pain (46%) and fatigue (28%) in cancer
patients, and dyspnea (52%) and dependency (37%) in
heart failure patients. Somatic complaints were reported
more frequently as a reason for EAS by cancer patients
[odds ratio (OR) 0.20, 95% confidence interval (CI) 0.09–
0.46] and heart failure patients [OR 0.16, 95% CI 0.05–
0.46] than by ALS patients. ALS patients should be helped
in a timely fashion to cope with psychosocial symptoms,
e.g., by informing them about the low risk of suffocation in
the terminal phase and the possible means of preventing
this.
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Introduction
In the final stage of life, patients often suffer from
physical, psychosocial or existential symptoms. When this
suffering becomes unbearable, patients may request the
physician to hasten their death [2] or explicitly for
euthanasia or physician-assisted suicide (EAS), even if it
is not legal for physicians to perform this [1, 14, 18]. In
most countries, it is currently illegal for physicians to
grant such requests. In The Netherlands, where EAS is
allowed under certain circumstances, 1.8% of all deaths in
2005 were the result of EAS [13]. Public perception is
that EAS is more frequently associated with cancer, as
this is far commoner. Of all cancer patients who died in
The Netherlands, EAS was performed in 5% [13], com-
pared with 20% of ALS patient deaths [16] and 0.5% of
heart failure patient deaths [15].
Electronic supplementary material The online version of this
article (doi:10.1007/s00415-010-5474-y) contains supplementary
material, which is available to authorized users.
M. Maessen  J. H. Veldink (&)  L. H. van den Berg 
H. J. Schouten
Department of Neurology, University Medical Centre Utrecht,
P.O. Box 85500, 3508 GA Utrecht, The Netherlands
e-mail: jveldink@umcutrecht.nl
M. Maessen
e-mail: m.maessen-2@umcutrecht.nl
G. van der Wal  B. D. Onwuteaka-Philipsen
Department of Public and Occupational Health, The EMGO
Institute, VU University Medical Centre, Amsterdam,
The Netherlands
123
J Neurol (2010) 257:1192–1198
DOI 10.1007/s00415-010-5474-y
One of the mandatory conditions in Dutch law for per-
forming EAS is that the patient requesting EAS is suffering
unbearably and the outlook is hopeless. More insight into
the disease-specific aspects of suffering which cause
patients to prefer death over life may help to improve
palliative care.
In the present study, we wanted to gain insight into the
physical and psychological symptoms of ALS patients who
requested EAS and into the factors that made their suf-
fering unbearable. To study disease-specific differences,
we compared the results of ALS patients with those of
cancer and heart failure patients, two groups with a lower
EAS proportion than in ALS patients. Together, these three
groups represent a disease with a high EAS proportion
(ALS), a disease with a low EAS proportion (heart failure),
and a disease most frequently associated with EAS
(cancer).
Patients and methods
Design and population
The data used in this study were collected for the Support
and Consultation in Euthanasia in The Netherlands
(SCEN) evaluation study [10]. SCEN is a governmental
healthcare organization that provides physicians (SCEN
physicians) who can be consulted for a second opinion by
treating physicians of patients who are considering or
requesting EAS. SCEN physicians can also give expert
advice to colleagues who have questions about EAS.
SCEN physicians are trained in palliative care and the
requirements of due care for performing EAS according
to Dutch law. During a formal consultation, the SCEN
physician talks with the treating physician, reads the
patient’s medical file, and visits the patient, in order to
come to a judgment on whether all requirements for due
care are met. The consultant records his reasoned judg-
ment in a consultation report. Examples of summaries of
such consultation reports are presented in box 1 of the
Supplementary Material. In the SCEN evaluation study,
all consultations by SCEN physicians were registered.
Shortly after each consultation, the SCEN physician filled
out a questionnaire on the consultation and sent it toge-
ther with a copy of the consultation report to the
researchers. SCEN physicians also handed a questionnaire
to the treating physician, who could send the question-
naire back to the researchers. All questionnaires and
consultation reports were anonymous, but by using a
registration number, the treating physician’s questionnaire
could be linked to the consultant’s questionnaire and
report. The Medical Ethical Committee approved the
study protocol.
Study population
Since 1999, SCEN has been gradually implemented in The
Netherlands, being available to 60% of all primary care
physicians since the first half of 2001, and to all primary
care physicians and some specialists since the second half
of 2002. Consultation reports and treating physicians’
questionnaires for this study were collected between April
1, 2000 and January 1, 2003.
The 495 available SCEN physicians sent a total of 3,891
SCEN questionnaires to the researchers, and 3,337 (86%)
treating physician questionnaires were also returned. From
these questionnaires we selected all questionnaires on
patients with diagnosis of ALS (n = 52) and heart failure
(n = 68). For 51 ALS patients and 61 heart failure patients
the corresponding SCEN consultation report was also
available. In addition we randomly selected 80 patients
from all those with diagnosis of cancer (n = 2,842); in 73
of them a SCEN consultant report was available as well.
Both patients whose request for EAS was granted and those
whose request did not result in EAS were included in this
study. As SCEN was gradually and randomly implemented
in The Netherlands, a random subset of all patients
requesting euthanasia in The Netherlands at that time was
available to us.
In the present study, euthanasia and physician-assisted
suicide (EAS) was defined as follows: physicians admin-
ister, supply or prescribe a drug with the explicit intention
to end the patient’s life (or to enable the patient to end his
or her own life), at the explicit request of the patient.
Questionnaires
Besides questions on the consultation by the SCEN
physician, which were relevant for the evaluation of
SCEN, the questionnaire for the consulting treating
physicians contained further questions on sex, age,
diagnosis, and physical and depressive symptoms at the
moment of consultation of the patient requesting EAS.
Symptoms of depression were measured using a short
version of a validated mood dimension scale, the Nurses’
Observation Scale for Geriatric Patients (NOSGER) [17].
Treating physicians also had to state whether EAS was
performed.
The written consultation report of the SCEN physician
consists of a text indicating the patient’s medical situa-
tion, and a reasoned answer to the question whether or not
the requirements for due care are met. The way of doing
this was typically to discuss each of the substantive
requirements for due care, including a well-considered
voluntary request from the patient, the presence of
unbearable and hopeless suffering, and the absence of
realistic alternatives for treatment. Two independent
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researchers assessed each consultation report. They
determined which aspects of suffering were the reasons
for the patient’s suffering being unbearable. A compre-
hensive list of possible aspects of suffering was used to
categorize the unbearable nature of suffering at the end of
life. If the two researchers did not score the same codes
for suffering, they discussed the SCEN report together to
reach consensus.
Data analysis
To analyze differences in sex and age, we used the chi-
square test and the t test. The physical and depressive
symptoms were measured using a five-point scale, on
which lower values indicated fewer symptoms. When
patients reported 1 or 2 on these five-point scales, symp-
toms were assumed to be absent. When patients reported 3,
4 or 5 on the five-point scale, symptoms were assumed to
be present (Tables 1, 2). Differences between ALS, cancer,
and heart failure patients regarding symptoms and reasons
for unbearable suffering were calculated using multivariate
logistic regression analysis, which was adjusted for sex and
age at time of EAS request. Aspects of unbearable suffer-
ing that were based on similar underlying conditions were
combined together into more general categories and are
presented in Table 4. The provided tables have a maximum
of six missing patients.
Results
Patient characteristics
Forty-nine percent of the ALS patients, 37% of the cancer
patients, and 46% of the heart failure patients were women.
Average age at time of EAS request was 65 years for ALS,
66 years for cancer, and 80 years for heart failure patients.
The distribution of sex did not differ significantly between
the three patients groups (p C 0.18). The heart failure
patients were significantly older than the ALS (p B 0.001)
and the cancer patients (p B 0.001).
During the SCEN evaluation study, 28 of the 51 ALS
patients died due to EAS, 1 patient had his or her request
for EAS denied, 2 patients changed their mind, and 5
patients died before EAS could be performed. In ten
patients, the study period ended before the physician
decided on the EAS request, one patient died before the
physician decided on the EAS, and in four patients it was
unknown what the outcome was. Forty-five of the 73
cancer patients died due to EAS, 2 patients had their
request for EAS denied, 4 patients changed their mind, and
7 patients died before EAS could be performed. Forty-one
of the 61 heart failure patients died due to EAS, 4 patients
had their request for EAS denied, 3 patients changed their
mind, and 7 patients died before EAS could be performed.
All other patients died before the physician decided on the
Table 1 Symptoms of patients at time of request for euthanasia or physician-assisted suicide according to treating physician
Symptoms ALS patients,
% (n = 51)
Cancer patients,
% (n = 73)
Heart failure patients,
% (n = 61)
ALS–cancer ALS–heart failure
OR 95% CI OR 95% CI
Not active 92 96 98 0.49 ns 0.18 ns
Feeling sick 92 97 98 0.30 ns 0.23 ns
Fatigue 80 96 97 0.17 0.04–0.66 0.12 0.02–0.68
Poor appetite 76 89 87 0.38 ns 0.18 0.05–0.65
Dyspnea 57 47 85 1.54 ns 0.24 0.08–0.72
Pain 33 63 43 0.27 0.12–0.59 0.70 ns
Frequently coughing 28 30 30 0.96 ns 0.78 ns
Anxious 28 34 28 0.62 ns 0.57 ns
Depressed 26 27 31 0.94 ns 0.73 ns
Nausea 16 62 44 0.11 0.04–0.27 0.34 0.11–0.99
Vomiting 8 42 18 0.09 0.03–0.31 0.27 ns
Pressure sores 8 13 12 0.64 ns 1.10 ns
Decreased consciousness 8 10 8 0.85 ns 0.67 ns
Confused 6 13 8 0.28 ns 0.29 ns
95% Confidence interval (95% CI) of the odds ratio (OR) for the various symptoms for amyotrophic lateral sclerosis (ALS) patients compared
with cancer patients (reference group) and ALS patients compared with heart failure patients (reference group), adjusted for sex and age
ALS amyotrophic lateral sclerosis, ns not significant
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EAS, or the study ended before the physician decided on
the EAS request. Thirteen patients had missing data.
Symptoms
According to the treating physicians, ALS patients dem-
onstrated the following symptoms less often than cancer
patients: fatigue (80% versus 96%), pain (33% versus
63%), nausea (16% versus 62%), and vomiting (8% versus
42%). Compared with heart failure patients, ALS patients
were less often fatigued (80% versus 97%), affected by
poor appetite (76% versus 87%), dyspneic (57% versus
85%), and nauseous (16% versus 44%) (Table 1).
Depressive symptoms
As shown in Table 2, no statistically significant differences
in the four NOSGER items on depressive symptoms, which
might indicate possible depression, were observed in ALS
patients compared with cancer patients or in ALS patients
compared with heart failure patients.
Unbearable suffering
Table 3 lists the five most frequently reported reasons
leading to the classification ‘‘unbearable suffering’’ in
ALS, cancer, and heart failure patients. The reasons for
unbearable suffering of the patient as recorded in the SCEN
consultation reports, combined into more general catego-
ries, are presented in Table 4.
Compared with cancer and heart failure patients, ALS
patients reported to the SCEN physician somatic symptoms
significantly less often as being unbearable. Physicians of
cancer patients indicated pain and fatigue significantly
more often as being unbearable than did physicians of ALS
patients. Dyspnea was more often a reason for the request
for heart failure patients than for ALS patients. In contrast
to physicians of cancer and heart failure patients, physi-
cians of ALS patients did not report gastrointestinal
symptoms, incontinence, pressure sores, or other somatic
complaints as a reason for requesting euthanasia. In addi-
tion, physicians of ALS patients reported dependency,
being limited in communication, and anxiety as reasons for
unbearable suffering more often than did physicians of
cancer patients.
Although the significance of difference could not be
tested due to small numbers, the percentages show that
immobility was an important reason for unbearable suf-
fering for all patients. Two kinds of immobility can be
distinguished here: for instance, paralyzed extremities, and
being bedridden due to fatigue or dyspnea. ALS patients
more frequently had paralyzed extremities as a reason for
their unbearable suffering (12% ALS, 0% cancer and heart
failure patients), while heart failure patients more
Table 2 Depressive symptoms of patients at time of request for euthanasia or physician-assisted suicide according to treating physician
Symptoms ALS patients,
% (n = 51)
Cancer patients,
% (n = 73)
Heart failure patients,
% (n = 61)
ALS–cancer ALS–heart failure
OR 95% CI OR 95% CI
Feeling worthless 34 30 41 1.45 ns 1.01 ns
Feeling depressed 32 33 36 0.90 ns 0.87 ns
Was in a happy mood 54 49 41 1.32 ns 1.20 ns
Interested in upcoming events 53 43 35 1.45 ns 1.25 ns
95% Confidence interval (95% CI) of the odds ratio (OR) for depressive symptoms for amyotrophic lateral sclerosis (ALS) patients compared
with cancer patients (reference group) and ALS patients compared with heart failure patients (reference group), adjusted for sex and age
ALS amyotrophic lateral sclerosis, ns not significant
Table 3 Top five most reported uncombined reasons for unbearable suffering
ALS patients (n = 51) Cancer patients (n = 73) Heart failure patients (n = 61)
1 Fear of suffocation 45% Pain 46% Dyspnea 52%
2 Dependency 29% Fatigue 28% Dependency 37%
3 Loss of dignity 20% Loss of dignity 24% Knowing that the suffering will only get worse 30%
4 Dyspnea/poor communication 16% Dependency 18% Being bedridden 25%
5 Fear of dependency 14% Dyspnea 17% Pain 23%
ALS amyotrophic lateral sclerosis
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frequently had being bedridden as the reason for their
unbearable suffering (25% heart failure patients, 4% cancer
patients, 0% ALS patients). None of the SCEN physicians
of ALS patients reported symptoms of depression as a
reason for unbearable suffering. Seven percent of the
cancer patients and 8% of the heart failure patients scored
at least one symptom of depression. These symptoms of
depression consisted of three subcategories based on the
DSM IV classification of depression: feeling excessively
guilty, depressed mood, and diminished interest or pleasure
in all, or almost all, activities for most of the day, nearly
every day, for a minimum of two consecutive weeks.
Discussion
This study showed that fear of suffocation is the most
frequently mentioned reason for unbearable suffering in
ALS patients presenting with an EAS request. In cancer
and heart failure patients with an EAS request, somatic
complaints are the most important reasons for unbearable
suffering.
Strengths of our study are the high response rate, the
anonymity of the respondents, and minimal chance of
recall bias because the reports were completed shortly after
the consultation. A limitation is the lack of patient
Table 4 Reasons for unbearable suffering of patients with a euthanasia or physician-assisted suicide request
Reasons ALS patients,
% (n = 51)
Cancer patients,
% (n = 73)
Heart failure patients,
% (n = 61)
ALS–cancer ALS–heart failure
OR 95% CI OR 95% CI
Psychosocial 96 88 92 1.26 ns 1.76 ns
Anxiousa 65 39 25 2.73 1.26–5.92 3.95 1.49–10.45
Fear of increase in somatic complaints 12 15 10 0.63 ns 0.60 ns
Fear of coma/of vegetating 10 1 2 7.07 ns 4.97 ns
Fear of dependence 14 7 2 1.99 ns 4.16 ns
Fear of not being able to communicate 10 3 0 3.82 ns – –
Fear of suffocation 45 11 3 6.61 2.48–17.65 14.66 2.86–75.12
Dependencya 39 21 42 2.41 1.05–5.55 2.66 ns
Hopelessnessa 27 22 33 1.16 ns 0.76 ns
Loss of dignitya 20 24 8 0.70 ns 2.05 ns
Limited communicationa 18 1 7 14.90 1.80–123.1 3.84 ns
Limited in leisure, work or personal carea 14 17 23 0.87 ns 0.61 ns
General depressive thoughtsa 12 15 3 0.79 ns 6.06 ns
Other psychosocial reasonsa 10 7 8 1.50 ns 3.56 ns
Cognitive decreasea 2 7 3 0.27 ns 1.08 ns
Feeling a burden on othersa 2 3 0 0.76 ns – –
Symptoms of depressiona 0 7 8 – – –
Somatic 51 83 85 0.20 0.09–0.46 0.16 0.05–0.46
Immobilitya 29 22 40 1.45 ns 0.84 ns
Dyspneaa 16 18 52 0.70 ns 0.12 (0.04–0.41)
Fatiguea 14 45 25 0.22 (0.08–0.59) 0.44 ns
Pain 12 46 23 0.16 (0.06–0.42) 0.30 ns
Difficulty swallowing 10 3 2 3.58 ns 6.34 ns
Gastrointestinal complaintsa 0 18 12 – – – –
Incontinencea 0 4 12 – – – –
Pressure sores 0 4 10 – – – –
Other somatic reasonsa 0 8 18 – – – –
95% Confidence interval (95% CI) of the odds ratio (OR) for the various reasons for unbearable suffering for amyotrophic lateral sclerosis (ALS)
patients compared with cancer patients (reference group) and ALS patients compared with heart failure patients (reference group), adjusted for
sex and age
ALS amyotrophic lateral sclerosis
–, cannot be calculated due to empty cells
a Similar reasons for unbearable suffering are combined together in this more general category
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perspectives on symptoms and suffering, as the respon-
dents were consultants and treating physicians. Another
limitation is the fact that the treating physician reported
symptoms of the patients using a standard list, which did
not include all typical disease-specific symptoms. Never-
theless, in the SCEN reports, in which physicians were free
to report every type of suffering, we found comparable
physical symptoms. Furthermore, this study focuses mainly
on primary care physicians, who in fact do receive the
majority of requests for EAS in The Netherlands [11].
Previous research showed that ALS patients who died
by EAS did not differ from ALS patients who did not
request EAS regarding physical function (mobility and
communication) [16]. This indicates that there may be
factors, other than physical symptoms, that explain the high
proportion of EAS in ALS patients. In our study, treating
physicians of ALS patients with an EAS request reported
fewer physical symptoms compared with treating physi-
cians of cancer and heart failure patients with an EAS
request. These findings suggest that, in ALS patients,
psychosocial reasons and especially anxiety may play a
larger role in unbearable suffering than in cancer and heart
failure patients. The fewer physical symptoms in ALS
patients reported by the treating physician correspond to
the lower frequency of somatic complaints reported by
SCEN physicians as a reason for unbearable suffering of
ALS patients compared with cancer and heart failure
patients.
Dependence on others is a psychosocial reason for suf-
fering being unbearable that is mentioned frequently by all
patient groups. Dependency in ALS patients often is the
consequence of paralysis, while for cancer and heart failure
patients, dependency usually is caused by fatigue or
dyspnea.
Median survival of ALS patients after onset of first
symptoms is 3–5 years, although survival of more than
10 years has been reported [7]. The first symptoms of
ALS are usually muscle weakness and increased depen-
dency on others [12]. Psychosocial suffering in ALS
therefore may not be restricted to the terminal phase. In
general, muscle weakness in ALS may lead to more
severe dependence for a longer period of time than in
cancer and heart failure.
A possible explanation for the higher proportion of EAS
in ALS patients may be the lack of palliative alternatives.
Suffering caused by pain in cancer patients, or dyspnea in
heart failure patients, can be relieved by opioids, and in the
case of refractory symptoms by palliative sedation. In
psychosocial suffering in ALS patients, these treatments
are not an adequate option. In addition, for palliative
sedation, guidelines from the Royal Dutch Medical Asso-
ciation stipulate that life expectancy in continuous deep
sedation should be 2 weeks or less. Therefore it cannot be a
solution for medical or psychosocial problems in ALS that
occur before the terminal phase [5]. As psychosocial
symptoms cannot always be prevented, patients should be
helped to cope with these symptoms at the earliest possible
stage [4].
Although the percentage of ALS patients that actually
die following acute respiratory distress is small (0–3%), a
large percentage of ALS patients are afraid of suffocation
[3, 6, 9]. A retrospective study carried out in ALS care-
givers, however, reported that 52% of ALS patients had
moderate to severe choking episodes during the last
month of their life [8]. Adequately informing ALS
patients about the limited chance of experiencing an
unpleasant death due to suffocation and about ways of
preventing this may diminish their fear, ease their suf-
fering, and might influence the high EAS rate among ALS
patients.
Conclusions
Somatic complaints were reported significantly more fre-
quently as a reason for EAS by cancer and heart failure
patients than by ALS patients. ALS patients reported more
often fear, dependency, and communication problems;
however, it cannot be concluded that the high percentage of
EAS in ALS is a causal result of these symptoms. Never-
theless, these specific psychosocial symptoms are impor-
tant factors that need special attention when caring for ALS
patients.
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